Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/26/2022 | Press release | Distributed by Public on 01/26/2022 17:47
Please select the service you want to use:
Smartlinks | FIS - Fidelity National Information Services Inc. | Fidelity National Financial Inc. | News | Local News | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Shareholders | Internal Dealings | Public Companies | IT Service Companies | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Börse Frankfurt | Bolsa de Valores de São Paulo (B3) | Wiener Börse (ATX) | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | XETRA | NYSE American | NYSE ARCA Equities | BZX Exchange | Cboe Off Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | Investors Exchange (IEX) | NYSE Chicago | Bolsa Institucional de Valores (BIVA)
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact